RET and non-small cell lung carcinoma: However, MHY4571 did not improve cell viability in the LC-2/ad cell line harboring a CCDC6-RET fusion; this genetic alteration is the most frequent RET rearrangement observed in NSCLC [26] (Additional file 1 Fig. S5).